FY24 sbir phase I- mizar S/TAR high-throughput platform for identification of senescence altering therapeutics
Ended Purchase Order Awarded Last action
- Contract number
- 80NSSC24PB376
- Awardee
-
Mizar Therapeutics Inc. UEI QTYLAVN4EJR6
- Awarding agency
-
Shared Services Center
National Aeronautics and Space Administration
- Obligated
- $155,536
Award facts
- Contract value 100% obligated
- $155,536.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 500 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Woods Hole, Falmouth, MA, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $155,536 |
About this award
Mizar Therapeutics Inc., a small business concern, received a $155,536 Phase I Small Business Innovation Research (SBIR) award from a civilian federal agency on August 7, 2024. The contract is structured as a firm fixed-price purchase order with an ultimate completion date of February 6, 2025. Under this award, the company will develop the Mizar S/TAR High-Throughput Platform, a research tool designed for identifying therapeutics that can alter cellular senescence. Work will be performed in Woods Hole, Falmouth, Massachusetts.
This Phase I SBIR award represents an early-stage research and development effort to validate the technical feasibility and commercial potential of the proposed platform technology. As a set-aside contract for small businesses, this award reflects the federal government's commitment to fostering innovation in the small business sector while advancing research capabilities in aging-related therapeutics. The relatively modest Phase I funding level is consistent with SBIR program structure, which typically funds proof-of-concept work prior to larger Phase II development efforts.
Quick answers
Who was awarded contract 80NSSC24PB376?
80NSSC24PB376 was awarded to Mizar Therapeutics Inc. by Shared Services Center (National Aeronautics and Space Administration) on August 7, 2024.
How much is contract 80NSSC24PB376 worth?
The government has obligated $155,536 on 80NSSC24PB376.
Was contract 80NSSC24PB376 competed?
The extent of competition for 80NSSC24PB376 was full and open competition after exclusion of sources. The government received 500 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award